Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next?
Sanofi and Regeneron unveiled plans last year to restructure their longstanding partnership, and now there are bigger changes afoot, for Sanofi at least: The French drugmaker aims to sell most of its massive stake in its biotech partner. Sanofi detailed plans to unload about 22.8 million Regeneron shares, a stake worth some $ 13 billion. The sale would… Read More »